APRiCOT-B: Study to Evaluate Apricoxib in Combination With Lapatinib and Capecitabine in the Treatment of HER2/Neu+ Breast Cancer (TP2001-202)
Part of paid clinical trials in Tucson, Arizona.
- Sponsor
- Tragara Pharmaceuticals, Inc.
- Study ID
- NCT00657137
- Phase
- PHASE2
- Status
- Terminated
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- apricoxib + lapatinib + capecitabine — DRUGapricoxib: 100 mg tablets, 400 mg/day lapatinib: per package insert capecitabine: per package insert
- placebo + lapatinib + capecitabine — DRUGplacebo: 100 mg tablets, 400 mg/day lapatinib: per package insert capecitabine: per package insert
Study Details
This study will compare the anti-tumor efficacy of apricoxib and lapatinib/capecitabine with placebo and lapatinib/capecitabine as measured by time to disease progression and evaluate urinary PGE-M measurements or baseline COX-2 expression in tumor tissue by IHC as a surrogate selection criterion for patients who will benefit from future treatment with apricoxib.
Key Dates
- Start date
- Apr 30, 2008
- Status verified
- Mar 2012
- Primary completion
- Sep 30, 2009
- Completion
- Sep 30, 2009
Study Design
- Enrollment
- 12 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Aapricoxib + lapatinib + capecitabine
- Placebo Comparator: Bplacebo + lapatinib + capecitabine
Primary Outcome Measure
To determine the anti-tumor activity of the combination of apricoxib/lapatinib-capecitabine compared with placebo/lapatinib-capecitabine as measured by time to disease progression. [ Time Frame: Time to disease progression ]
Locations (44)
Find similar trials in Tucson, AZ
By condition
By specialty
By research site
Arizona Clinical Research Center· Tucson, AZComprehensive Blood and Cancer Center· Bakersfield, CAAlta Bates Summit Comprehensive Cancer Center· Berkeley, CABay Area Cancer Research Group, LLC· Concord, CASt. Jude Heritage Healthcare· Fullerton, CAWilshire Oncology Medical Group Inc· Inland Valleys/Pomona, CA
Related Studies
- Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA MutationsRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- Collecting Tissue Samples for Future Research From Women Undergoing Surgery for Breast CancerRecruiting · Northwestern University · Chicago, Illinois
- Collecting and Storing Tissue Samples From Women With or Without Breast CancerRecruiting · Vanderbilt-Ingram Cancer Center · Nashville, Tennessee
- Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood SamplesRecruiting · Stanford University · Stanford, California